Zhonghua yi xue za zhiHumansIrinotecanLiposomesConsensusDigestive System Neoplasms
[Expert consensus on the application of irinotecan liposomes in digestive system tumors (2025 edition)].
Committee of Digestive Tract Polyp and Precancerous Lesion, Chinese Anti-Cancer Association, Committee of Esophageal Cancer, Chinese Anti-Cancer Association, Committee of Colorectal Cancer, Chinese Anti-Cancer Association, Committee of Biliary Tract Tumors, Chinese Anti-Cancer Association, Chinese Gastric Cancer Association, The Committee of Pancreatic Cancer, Chinese Anti-Cancer Association
Published: 202510.3760/cma.j.cn112137-20250806-01991
Abstract
Gastrointestinal cancers are common malignant tumors posing a serious threat to human health. Irinotecan liposome, a recently approved chemotherapeutic agent primarily indicated for pancreatic cancer within the gastrointestinal malignancies, has seen…
Preview only. Read the full abstract at the source